Search for Clinical Trial Results

Sponsored By

Hepatic Insufficiency - 25 Studies Found

Status Study
Completed Study Name: The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009)
Condition: Hepatic Insufficiency
Date: 2013-02-20
Interventions: Drug: Elbasvir
Completed Study Name: Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Subjects With Moderate Hepatic Insufficiency (MK-0822-070)
Condition: Hepatic Insufficiency
Date: 2012-01-13
Interventions: Drug: Single Dose MK-0822 A one-time, single-dose (50 mg tablet) administered orally on Day 1
Completed Study Name: Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency
Condition: Hepatic Insufficiency
Date: 2014-09-23
Interventions:
  • Drug: Tipranavir (TPV)
  • Drug: Ritonavir (r)
Completed Study Name: Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)
Condition:
  • Insomnia
  • Hepatic Insufficiency

Date: 2010-01-05
Interventions: Drug: Suvorexant single 20 mg dose of suvorexant will be administered as 2 x 10 mg film coated tablets o
Completed Study Name: Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)
Condition:
  • Healthy Volunteers
  • Hepatic Insufficiency

Date: 2010-01-05
Interventions: Drug: ridaforolimus single oral dose administration 10 mg ridaforolimus
Completed Study Name: Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency
Condition: Hepatic Insufficiency
Date: 2009-08-27
Interventions: Drug: Everolimus
Completed Study Name: A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)
Condition: Liver Insufficiency
Date: 2008-06-11
Interventions: Drug: sitagliptin phosphate sitagliptin phosphate 100 mg MK0431 (2 x 50 mg tablets) taken orally after o
Completed Study Name: Single Dose of 9-cis-retinoic Acid in Hepatic Patients
Condition: Hepatic Insufficiency
Date: 2013-06-21
Interventions: Drug: 9-cis-retinoic acid Single dose of 9-cis-retinoic acid (Capsule 30 mg) as oral exposure
Completed Study Name: Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers
Condition: Hepatic Insufficiency
Date: 2014-10-15
Interventions: Drug: BIIL 284 BS
Completed Study Name: Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
Condition: Hepatic Insufficiency
Date: 2014-07-14
Interventions: Drug: Nintedanib Soft gelatine capsule
Next >>>